Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus. Free

Abstract

The capacity of novel subunit vaccines to generate cytotoxic T lymphocytes (CTLs) against hepatitis C virus (HCV) was assessed. BALB/c mice were immunized with peptides based on the CTL and helper T cell (Th) epitopes of the HCV core, with a mixture of CTL and Th peptides (CTL+Th) or with a conjugated Th-CTL peptide. Mice immunized with CTL, CTL+Th and Th-CTL peptides, but not those immunized with Th peptide, developed HCV core CTL epitope-specific effector cells. Cytotoxic activity induced by immunization with Th-CTL was much higher than that induced by immunization with CTL+Th or CTL alone. However, rapid and high cytotoxic activities against HCV core were not only detected after immunization with peptides containing the CTL epitope but also as a result of infection with recombinant vaccinia virus carrying the HCV core gene after immunization with the Th epitope alone. Immunization with peptides containing the Th epitope also elicited spleen cell proliferation. This study demonstrates the capacity of both Th and CTL activated peptide vaccines to elicit CD8, MHC class I-restricted CTLs. The capacity of such CTLs to contribute towards a protective and/or pathogenic immune response against HCV can now be assessed in mouse models.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-1-187
1999-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/1/0800187a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-1-187&mimeType=html&fmt=ahah

References

  1. Ada G. L. 1990; The immunological basis of vaccine development. Seminars in Virology 1:3–11
    [Google Scholar]
  2. Battegay M., Fikes J., Di Biscegglie A. M., Wentworth P. A., Sette A., Celis E., Ching W.-M., Grakoui A., Rice C. M., Kurokohchi K., Berzofsky J. A., Hoofnag J. H., Feinstone S. M., Akatsuka T. 1995; Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. Journal of Virology 69:2462–2470
    [Google Scholar]
  3. Bennett S. R. M., Carbone F. R., Karamalis F., Flavell R. A., Miller J. F. P., Heath W. R. 1998; Help for cytotoxic T-cell response is mediated by CD40 signalling. Nature 393:478–480
    [Google Scholar]
  4. Cardin R. D., Brooks J. W., Sarawar S. R., Doherty P. C. 1996; Progressive loss of CD8+ T cell-mediated control of a γ-herpesvirus in the absence of CD4+ T cells. Journal of Experimental Medicine 184:863–871
    [Google Scholar]
  5. Cerny A., McHutchinson J. G., Pasquinelli C., Brown M. E., Brothers M. A., Grabschied B., Fowler P., Houghton M., Chisari F. V. 1995; Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. Journal of Clinical Investigation 95:521–530
    [Google Scholar]
  6. Choo Q.-L., Kuo G., Weiner A., Overby L. R., Brady D. W., Houghton M. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362
    [Google Scholar]
  7. Diepolder H. M., Zachoval R., Hoffmann R. M., Wierenga E. A., Santantonio T., Jung M.-C., Eichenlaub D., Pape G. R. 1995; Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006–1007
    [Google Scholar]
  8. Diepolder H. M., Gerlach J. T., Zachoval R., Hoffmann R. M., Jung M.-C., Wierenga E. A., Scholz S., Santantonio T., Houghton M., Southwood S., Sette A., Pape G. R. 1997; Immunodominant CD4+ T-cell epitope within nonstructural protein in acute hepatitis C virus infection. Journal of Virology 71:6011–6019
    [Google Scholar]
  9. Ferrari C., Valli A., Galati L., Penna A., Scaccaglia P., Giuberti T., Schianchi C., Missale G., Marin M. G., Fiaccadori F. 1994; T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286–295
    [Google Scholar]
  10. Fujiwara H., Fukuzawa M., Yoshioka T., Nakajima H., Hamaoka T. 1984; The role of tumor-specific Lyt-1+2 T cells in eradicating tumor cells in vivo. I. Lyt-1+2 T cells do not necessarily require recruitment of host’s cytotoxic T cell precursors for implementation of in vivo immunity. Journal of Immunology 133:1671–1676
    [Google Scholar]
  11. Greenberg P. D., Cheever M. A., Fefer A. 1981; Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2 lymphocytes. Journal of Experimental Medicine 154:952–963
    [Google Scholar]
  12. Houghton M., Weiner A., Han J., Kuo G., Choo Q.-L. 1991; Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381–388
    [Google Scholar]
  13. Husmann L. A., Bevan M. J. 1988; Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Annals of the New York Academy of Sciences 532:158–161
    [Google Scholar]
  14. Imawari M., Nomura M., Kaieda T., Moriyama T., Oshimi K., Nakamura I., Gunji T., Ohnishi S., Ishikawa T., Nakagama H., Takaku F. 1989; Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus. Proceedings of the National Academy of Sciences, USA 86:2883–2887
    [Google Scholar]
  15. Kakimi K., Kuribayashi K., Iwashiro M., Masuda T., Sakai M., Ling W., Kubo Y., Kobayashi H., Higo K., Seki M., Honda Y., Yamada E., Matsuura Y., Miyamura T., Okuma M., Ishimoto A. 1995; Hepatitis C virus core region: helper T cell epitopes recognized by BALB/c and C57BL/6 mice. Journal of General Virology 76:1205–1214
    [Google Scholar]
  16. Kast W. M., Bronkhorst A. M., de Waal L. P., Melief C. J. M. 1986; Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations. Journal of Experimental Medicine 164:723–738
    [Google Scholar]
  17. Koike K., Moriya K., Ishibashi K., Matsuura Y., Suzuki T., Saito I., Iino S., Kurokawa K., Miyamura T. 1995; Expression of hepatitis C virus envelope proteins in transgenic mice. Journal of General Virology 76:3031–3038
    [Google Scholar]
  18. Koike K., Moriya K., Ishibashi K., Yotsuyanagi H., Shintani Y., Fujie H., Kurokawa K., Matsuura Y., Miyamura T. 1997; Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proceedings of the National Academy of Sciences, USA 94:233–236
    [Google Scholar]
  19. Kuo G., Choo Q.-L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E., Tegtmeier G., Bonino F., Colombo M., Lee W. S., Kuo G., Berger K., Shuster J., Overby L., Bradley D., Houghton M. 1989; An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364
    [Google Scholar]
  20. Lu S., Arthos J., Montefiori D. C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J. C., Wissink J., Mullins J. I., Haynes J. R., Letvin N. L., Wyand M., Robinson H. L. 1996; Simian immunodeficiency virus DNA vaccine trial in macaques. Journal of Virology 70:3978–3991
    [Google Scholar]
  21. Matloubian M., Concepcion R. J., Ahmed R. 1994; CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. Journal of Virology 68:8056–8063
    [Google Scholar]
  22. Matsuda J., Suzuki S., Nozaki C., Shinya N., Tashiro K., Mizuno K., Uchino Y., Yamamura K. 1998; Transgenic mouse expressing a full-length hepatitis C virus cDNA. Japanese Journal of Cancer Research 89:150–158
    [Google Scholar]
  23. Missale G., Bertoni R., Lamonaca V., Valli A., Massari M., Mori C., Rumi M. G., Houghton M., Fiaccadori F., Ferrari C. 1996; Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. Journal of Clinical Investigation 98:706–714
    [Google Scholar]
  24. Miyazawa M., Fujisawa R., Ishihara C., Takei Y. A., Shimizu T., Uenishi H., Yamagishi H., Kuribayashi K. 1995; Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development. Journal of Immunology 155:748–758
    [Google Scholar]
  25. Mochizuki K., Hayashi N., Kitayama K., Hiramatsu N., Kanto T., Mita E., Tatsumi T., Kuzushita T., Kasahara A., Fusamoto H., Yokochi T., Kamada T. 1997; B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C. Hepatology 25:713–718
    [Google Scholar]
  26. Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Ishibashi K., Matsuura Y., Miyamura T., Koike K. 1997; Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. Journal of General Virology 78:1527–1531
    [Google Scholar]
  27. Morrison L. A., Lukacher A. E., Braciale V. L., Fan D. P., Braciale T. J. 1986; Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. Journal of Experimental Medicine 163:903–921
    [Google Scholar]
  28. Nelson D. R., Marousis C. G., Davis G. L., Rice C. M., Wong J., Houghton M., Lau J. Y. N. 1997; The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. Journal of Immunology 158:1473–1481
    [Google Scholar]
  29. Ossendorp F., Mengede E., Camps M., Filius R., Melief C. J. M. 1998; Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. Journal of Experimental Medicine 187:693–702
    [Google Scholar]
  30. Pasquinelli C., Shoenberger J. M., Chung J., Chang K. M., Guidotti L. G., Selby M., Berger K., Lesniewski R., Houghton M., Chisari F. V. 1997; Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 25:719–727
    [Google Scholar]
  31. Rehermann B., Chang K.-M., McHutchinson J., Nokka R., Houghton M., Rice C. M., Chisari F. V. 1996; Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. Journal of Virology 70:7092–7102
    [Google Scholar]
  32. Ridge J. P., Di Rosa F., Matzinger P. 1998; A conditional dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474–478
    [Google Scholar]
  33. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q.-L., Houghton M., Kuo G. 1990; Hepatitis C virus infection is associated with development of hepatocellular carcinoma. Proceedings of the National Academy of Sciences, USA 87:6547–6549
    [Google Scholar]
  34. Schoenberger S. P., Toes R. E. M., van der Voort E. I. H., Offringa R., Melief C. J. M. 1998; T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480–483
    [Google Scholar]
  35. Shirai M., Akatsuka T., Pendleton C. D., Houghten R., Wychowski C., Mihalik K., Feinstone S., Berzofsky J. A. 1992; Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. Journal of Virology 66:4098–4106
    [Google Scholar]
  36. Shirai M., Pendleton C. D., Ahlers J., Takeshita T., Newman M., Berzofsky J. A. 1994a; Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. Journal of Immunology 152:549–556
    [Google Scholar]
  37. Shirai M., Okada H., Nishioka M., Akatsuka T., Wychowski C., Houghten R., Pendleton C. D., Feinstone S. M., Berzofsky J. A. 1994b; An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. Journal of Virology 68:3334–3342
    [Google Scholar]
  38. Shirai M., Arichi T., Nishioka M., Nomura T., Ikeda K., Kawanishi K., Engelhard V. H., Feinstone S. M., Berzofsky J. A. 1995; CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. Journal of Immunology 154:2733–2742
    [Google Scholar]
  39. Shirai M., Chen M., Arichi T., Masaki T., Nishioka M., Newman M., Nakazawa T., Feinstone S. M., Berzofsky J. A. 1996; Use of intrinsic and extrinsic helper epitopes for in vivo induction of antihepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines. Journal of Infectious Diseases 173:24–31
    [Google Scholar]
  40. Singer A., Hodes R. J. 1983; Mechanisms of T cell–B cell interaction. Annual Review of Immunology 1:211–241
    [Google Scholar]
  41. Van Snick J., Maryanski J., Van Pel A., Parmiani G., Boon T. 1982; Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens. European Journal of Immunology 12:905–908
    [Google Scholar]
  42. von Boehmer H., Haas W. 1979; Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen. Journal ofExperimental Medicine 150:1134–1142
    [Google Scholar]
  43. Wagner H., Statzinski-Powitz A., Pfizenmaier K., Rollinghoff M. 1976; T-T cell collaboration during in vivo responses to antigens coded by the peripheral and central region of the MHC. Nature 263:235–237
    [Google Scholar]
  44. Yasutomi Y., Palker T. J., Gardner M. B., Haynes B. F., Letvin N. L. 1993; Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. Journal of Immunology 151:5096–5105
    [Google Scholar]
  45. Yasutomi Y., Robinson H. L., Lu S., Mustafa F., Lekutis C., Arthos J., Mullins J. I., Voss G., Manson K., Wyand M., Letvin N. L. 1996; Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. Journal of Virology 70:678–681
    [Google Scholar]
  46. Zinkernagel R. M., Callahan G. N., Althage A., Cooper S., Streilein J. W., Klein J. 1978; The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. Journal of Experimental Medicine 147:897–911
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-1-187
Loading
/content/journal/jgv/10.1099/0022-1317-80-1-187
Loading

Data & Media loading...

Most cited Most Cited RSS feed